CD8A and neoplasm: The OT-I T cells carry transgenic inserts for the Tcra-V2 and Tcrb-V5 genes designed to recognize an ovalbumin epitope, thereby directing the cells to the tumor and eliciting a CD8 positive T cells response to tumor cells expressing ovalbumin antigens [20].